文献速递肝病消化道肿瘤与早癌

SNORA18L5 种系重复增加 HBV 相关肝细胞癌风险:改变核糖体蛋白定位并降低 p53 水平

Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels of p53.
PubMed 文献 · Gastroenterology · 2018-04-24

在中国人群中开展基于拷贝数变异的全基因组关联研究,纳入 1583 例 HBV 相关肝细胞癌病例和 1540 例慢性 HBV 感染对照,发现 15q13.3 低频重复与肝癌风险强相关(总体 P=3.17×10⁻⁸,OR=12.02)。该重复拷贝数与 SNORA18L5 表达相关,SNORA18L5 通过促进核糖体生物合成、使 RPL5/RPL11 滞留核仁,增加 MDM2 介导的 p53 降解,促进肝癌细胞增殖和裸鼠移植瘤生长。

要点

  • 15q13.3 低频重复与 HBV 相关肝癌风险强相关(总体 P=3.17×10⁻⁸,OR=12.02)。
  • SNORA18L5 过表达促进肝癌细胞增殖和裸鼠移植瘤生长,敲低则抑制。
  • SNORA18L5 使 RPL5/RPL11 滞留核仁,增加 MDM2 介导的 p53 降解。

核心结论

  • 基于拷贝数变异的全基因组关联研究将 15q13.3 重复与 HBV 相关肝细胞癌风险增加相关联。
  • 位于该位点的 SNORA18L5 促进肝癌细胞增殖和小鼠肿瘤生长。
  • SNORA18L5 增加核糖体生物合成、促进核糖体 RNA 成熟并改变 RPL5 和 RPL11 定位,从而增加 MDM2 介导的 p53 蛋白水解和细胞周期阻滞。

研究设计与样本

  • 在中国人群中开展基于种系拷贝数变异的全基因组关联研究,纳入 1583 例 HBV 相关肝细胞癌病例和 1540 例慢性 HBV 感染对照。
  • 在 L-02、HepG2、TP53-/- 或野生型 HCT116 细胞中表达候选基因,并在 HepG2、Bel-7402 和 SMMC-7721 细胞中用短发夹 RNA 敲低,检测增殖、集落形成和凋亡。
  • 在裸鼠中监测细胞系来源的移植瘤形成。
  • 通过免疫共沉淀、免疫荧光和免疫印迹分析核糖体蛋白亚细胞定位及 p53 水平或活性。
  • 用定量逆转录聚合酶链反应检测 SNORA18L5 水平。

主要发现

  • 鉴定出染色体 15q13.3 低频重复与 HBV 相关肝细胞癌风险强相关(总体 P=3.17×10⁻⁸;比值比 12.02)。
  • 15q13.3 重复拷贝数与肝组织中 SNORA18L5 表达相关。
  • SNORA18L5 过表达增加肝癌细胞增殖和小鼠移植瘤生长;敲低降低肝癌增殖和肿瘤生长。
  • HepG2 和 SMMC-7721 细胞中 SNORA18L5 过表达抑制 p53 依赖性细胞周期阻滞和凋亡。
  • SNORA18L5 过表达导致核糖体生物合成过度活跃,增加成熟 18S 和 28S 核糖体 RNA 水平,并使核糖体蛋白 RPL5 和 RPL11 滞留于核仁,阻止其与 MDM2 结合,从而增加 MDM2 介导的 p53 泛素化和降解。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Single nucleotide polymorphisms could affect risk for hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC). We performed a germline copy number variation (CNV)-based genome-wide association study (GWAS) in populations of Chinese ancestry to search for germline CNVs that increase risk of HCC. METHODS: We conducted a CNV-based GWAS of 1583 HCC cases (persons with chronic HBV infection and HCC) and 1540 controls (persons with chronic HBV infection without HCC) in Chinese populations. Identified candidates were expressed in L-02, HepG2, or TP53-/- or wild-type HCT116 cells, and knocked down with short hairpin RNAs in HepG2, Bel-7402, and SMMC-7721 cells; proliferation, colony formation, and apoptosis were measured. Formation of xenograft tumors from cell lines was monitored in nude mice. Subcellular localization of ribosome proteins and levels or activity of p53 were investigated by co-immunoprecipitation, immunofluorescence, and immunoblot analyses. Levels of small nucleolar RNA H/ACA box 18-like 5 (SNORA18L5) were quantified by quantitative reverse transcription polymerase chain reaction. RESULTS: We identified a low-frequency duplication at chromosome 15q13.3 strongly associated with risk of HBV-related HCC (overall P = 3.17 × 10-8; odds ratio, 12.02). Copy numbers of the 15q13.3 duplication correlated with the expression of SNORA18L5 in liver tissues. Overexpression of SNORA18L5 increased HCC cell proliferation and growth of xenograft tumors in mice; knockdown reduced HCC proliferation and tumor growth. SNORA18L5 overexpression in HepG2 and SMMC-7721 cells inhibited p53-dependent cell cycle arrest and apoptosis. Overexpression of SNORA18L5 led to hyperactive ribosome biogenesis, increasing levels of mature 18S and 28S ribosomal RNAs and causing the ribosomal proteins RPL5 and RPL11 to stay in the nucleolus, which kept them from binding to MDM2. This resulted in increased MDM2-mediated ubiquitination and degradation of p53. Levels of SNORA18L5 were increased in HCC tissues compared with nontumor liver tissues and associated with shorter survival times of patients. CONCLUSIONS: In a CNV-based GWAS, we associated duplication at 15q13.3 with increased risk of HBV-related HCC. We found SNORA18L5 at this location to promote HCC cell proliferation and tumor growth in mice. SNORA18L5 increases ribosome biogenesis, facilitates ribosomal RNA maturation, and alters localization of RPL5 and RPL11, allowing for increased MDM2-mediated proteolysis of p53 and cell cycle arrest.

来源:Gastroenterology,查看原文。版权归原作者所有。

引用

  1. Cao P, Yang A, Wang R, et al. Germline Duplication of SNORA18L5 Increases Risk for HBV-related Hepatocellular Carcinoma by Altering Localization of Ribosomal Proteins and Decreasing Levels of p53. Gastroenterology. 2018. PMID: 29702115. doi:10.1053/j.gastro.2018.04.020

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。